Our Partnerships

NKMax collaborations provide additional opportunities to fully leverage our proprietary NK cell therapy platforms.

Strategic Partnerships

NKMax is committed to establishing successful partnerships with innovators that share a common goal of developing treatments for patients with cancer and other immune related diseases. Our list of strategic partners is growing, and we are proud to be able to share our combined talents through collaborating, developing and improving upon processes that we hope will lead to ground-breaking therapies with the goal to improve patients’ lives through better outcomes and quality of life.

We are pleased to be partnering with the following leading life science companies:

Affimed-Logo

NKMax America is actively seeking strategic partners to accelerate the development of our NK cell therapy products by leveraging the unique capabilities each company. To connect with our business development team, please contact us via email at bd@nkmaxamerica.com.